Avalo Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Avalo Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2014 to Q3 2024.
  • Avalo Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $35.9M.
  • Avalo Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $54.9M.
  • Avalo Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$4.18M, a 0.26% increase from 2022.
  • Avalo Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$4.19M, a 73.8% decline from 2021.
  • Avalo Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$2.41M, a 143% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $54.9M $35.9M +$37.4M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $17.5M $108M +$109M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$91.5M -$88.5M -$87.4M -7564% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-07-11
Q4 2023 -$4.18M -$518K +$431K +45.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$4.61M -$1.47M -$572K -63.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$4.04M -$1.04M +$118K +10.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$4.16M -$1.16M +$34K +2.86% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-07-11
Q4 2022 -$4.19M -$949K +$235K +19.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$4.43M -$898K +$102K +10.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$4.53M -$1.15M -$910K -373% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$3.62M -$1.19M -$1.21M -7094% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$2.41M -$1.18M -$1.2M -10864% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$1.22M -$1M -$1.02M -5363% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$197K -$244K +$1.22M +83.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$1.42M $17K -$7.08M -99.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $5.67M $11K -$52.7K -82.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 $5.72M $19K -$33.7K -64% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $5.75M -$1.47M -$1.52M -2656% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $7.27M $7.1M +$7.13M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $147K $63.7K -$573K -90% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 $720K $52.7K +$291K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $429K $57.3K +$296K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $133K -$26.8K +$78.2K +74.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $54.9K $636K +$634K +32731% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 -$579K -$238K -$267K -908% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$312K -$238K -$215K -914% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$97.1K -$105K -$43.5K -70.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$53.6K $1.94K -$45.7K -95.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$7.94K $29.5K +$235K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$243K -$23.5K +$12.6K +34.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$255K -$61.5K +$136K +68.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$392K $47.6K +$20.7K +76.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$412K -$205K -$1.47M -116% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $1.06M -$36.1K -$14.7K -68.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $1.08M -$198K +$556K +73.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $520K $26.9K Oct 1, 2015 Dec 31, 2015 10-K 2018-04-02
Q3 2015 $1.27M +$1.11M +699% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$21.4K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$754K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 $159K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.